Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Bhatia

Showing results (141-150 of 220) with videos related to

Pageof 22
Sort By:
Journal of the National Cancer Institute|July 2, 2025
Clonal hematopoiesis and subsequent venous thromboembolism among survivors of autologous transplantation for lymphomaRadhika Gangaraju, Yanjun Chen, Lindsey Hageman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphomaRavi Bhatia, Khristine Van Heijzen, Ann Palmer, et al.
EMBO Molecular Medicine|January 24, 2013
A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemiaJiewen Zhu, Longen Zhou, Guikai Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2015
Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemiaHelena Ågerstam, Christine Karlsson, Nils Hansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2022
Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor StudySaro H Armenian, Yanjun Chen, Lindsay Hageman, et al.
Blood|January 5, 2013
TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivoQifang Zhang, Dewan Md Sakib Hossain, Sergey Nechaev, et al.
Journal of the National Cancer Institute|January 31, 2025
Human papillomavirus-related squamous cell carcinomas after blood or marrow transplantation-a Blood or Marrow Transplant Survivor Study reportAnna Sällfors Holmqvist, Qingrui Meng, Wendy Landier, et al.
Cancer Cell|November 19, 2011
Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia/acute myeloid leukemia and identifies patients at riskLiang Li, Min Li, Canlan Sun, et al.
Transplantation and Cellular Therapy|May 7, 2026
Suicidal Ideation experienced by long-term survivors of Blood or Marrow Transplantation: a BMTSS ReportRitika Samant, Devika Bhatia, Qingrui Meng, et al.
JACC. Cardiooncology|August 24, 2023
Prediction of Coronary Heart Disease Events in Blood or Marrow Transplantation RecipientsRadhika Gangaraju, Yanjun Chen, Lindsey Hageman, et al.
Pageof 22

Showing results (141-150 of 220) with videos related to

Sort By:
Pageof 22
Journal of the National Cancer Institute|July 2, 2025
Clonal hematopoiesis and subsequent venous thromboembolism among survivors of autologous transplantation for lymphomaRadhika Gangaraju, Yanjun Chen, Lindsey Hageman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Longitudinal assessment of hematopoietic abnormalities after autologous hematopoietic cell transplantation for lymphomaRavi Bhatia, Khristine Van Heijzen, Ann Palmer, et al.
EMBO Molecular Medicine|January 24, 2013
A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemiaJiewen Zhu, Longen Zhou, Guikai Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2015
Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemiaHelena Ågerstam, Christine Karlsson, Nils Hansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2022
Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor StudySaro H Armenian, Yanjun Chen, Lindsay Hageman, et al.
Blood|January 5, 2013
TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivoQifang Zhang, Dewan Md Sakib Hossain, Sergey Nechaev, et al.
Journal of the National Cancer Institute|January 31, 2025
Human papillomavirus-related squamous cell carcinomas after blood or marrow transplantation-a Blood or Marrow Transplant Survivor Study reportAnna Sällfors Holmqvist, Qingrui Meng, Wendy Landier, et al.
Cancer Cell|November 19, 2011
Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia/acute myeloid leukemia and identifies patients at riskLiang Li, Min Li, Canlan Sun, et al.
Transplantation and Cellular Therapy|May 7, 2026
Suicidal Ideation experienced by long-term survivors of Blood or Marrow Transplantation: a BMTSS ReportRitika Samant, Devika Bhatia, Qingrui Meng, et al.
JACC. Cardiooncology|August 24, 2023
Prediction of Coronary Heart Disease Events in Blood or Marrow Transplantation RecipientsRadhika Gangaraju, Yanjun Chen, Lindsey Hageman, et al.
Pageof 22